Latest News
Latest News and Events
- All
- Events
- Featured
- Imspex Clinical
- Imspex Industrial
Business Update Following Fire at Navigation Park, Abercynon
We would like to inform our customers, partners, suppliers and stakeholders that a fire occurred today at the business park where Imspex Diagnostics is based ...
Read More →
Siloxane monitoring
Protecting engines, turbines, and upgrading systems Siloxanes remain a persistent challenge in biogas, landfill gas, and biomethane production. When combusted, these silicon-containing compounds form abrasive ...
Read More →
GC-IMS – Seeing molecules differently
Why GC-IMS is becoming the platform for rapid VOC intelligence Volatile organic compounds carry information — about flavour, contamination, process drift, safety, and biological state.The ...
Read More →
Food & Flavour
From sensory judgement to objective molecular fingerprints Sensory panels remain a gold standard — but they are costly, limited in scope, difficult to redeploy across ...
Read More →
Industrial & process monitoring
Real-time VOC monitoring without GC-MS complexity Traditional VOC monitoring typically means: GC-IMS offers a different route: Applications already proven: We offer demos, collaborative GC-IMS access, ...
Read More →
Academic & Research
A new analytical workhorse for VOC-driven research GC-IMS is rapidly becoming a powerful research platform across:• Food science• Microbial metabolomics• Environmental chemistry• Biomedical VOC diagnostics ...
Read More →
Grant Highlight: TOXI-Triage
Imspex Diagnostics was a funded partner in the EU Horizon TOXI-Triage programme, a major European initiative focused on improving response capability during chemical and toxic ...
Read More →
Grant Highlight: ONELAB Project
Imspex Diagnostics was selected for the OneLab project, a collaborative initiative designed to accelerate the deployment of advanced analytical technologies into real-world environments. The programme ...
Read More →
Imspex at World Health Expo Dubai 2026
Imspex is exhibiting at the World Health Expo Dubai from Monday 9 – Thursday 12 February 2026, and we are based on the Welsh Pavilion ...
Read More →
Business Development (Analytical Chemistry / Biology / Instrumentation)
Imspex Diagnostics is expanding its commercial team and we’re looking for a standout Business Development professional with a proven track record in analytical instrumentation. You’ll ...
Read More →
Imspex joins the Welsh Delegation at MEDICA 2025
Imspex Diagnostics joins Welsh Delegation at MEDICA, DĂĽsseldorf Next week, Amber Jacobs, PR, Marketing & ESG Compliance Leader at Imspex Diagnostics, will be joining the ...
Read More →
Imspex Diagnostics at LSX Investival 2025
Imspex Diagnostics at LSX Investival Showcase, London Imspex Diagnostics CEO John McKinley and CFO Toby Wilson Waterworth will be attending the LSX Investival Showcase in ...
Read More →
Imspex at the IABR Summit 2025
Representing Imspex Diagnostics at the forefront of global breath research Our Senior Research Scientist & Technical Support, Hannah Deane-Cutler, recently attended the International Association of ...
Read More →
Imspex to Present at BioSeed 2025
We’re pleased to share that Imspex Diagnostics will be represented at BioSeed 2025, taking place on 9 June in London. Hosted by OBN, BioSeed is ...
Read More →
Imspex at Arab Health 2025
Imspex Diagnostics is proud to announce our participation at Arab Health 2025, one of the world’s largest healthcare exhibitions, taking place from 27th to 30th ...
Read More →
Imspex & Biophys Partner to Drive SMART Diagnostics at New South Wales Lab
We are pleased to announce a significant collaboration between Imspex Diagnostics Ltd and Biophys Limited, aimed at advancing SMART diagnostics and R&D services. This partnership ...
Read More →
David Wilson Joins Imspex as Non-Executive Director
Imspex Diagnostics is pleased to announce the appointment of David Wilson to our board of directors as a Non-Executive Director. David brings over 30 years ...
Read More →
IMSPEX NEWS
PRESS RELEASE Imspex Announces Sale of Its German Subsidiary, Paving the Way for Standalone UK Entity Dedicated to Advancing Clinical Diagnostics and Leading in Breathomics. ...
Read More →
Meet Robin Curnow
📢IMSPEX Announcement: This week, Imspex presents our doctoral student, Robin Curnow, co-sponsored by us and the University of Manchester. Robin shares insights into his impactful ...
Read More →
Meet Trenton Stewart
IMSPEX is proud to announce some of the current and upcoming projects led by one of our doctoral students, Trenton Stewart, co-sponsored by us and ...
Read More →
BioWales in London
Tuesday 5th March, Canary Wharf, London IMSPEX is excited to share that our Group CEO, John McKinley, will be delivering a presentation at the MediWales ...
Read More →
BioWales in London Pre-Event at The Shard
We’re pleased to announce that our Group CEO John McKinley will be participating in a panel discussion at Mathys & Squire IP Firm, located at The Shard ...
Read More →
IMSPEX Achieves New ISO Standard
We are pleased to announce that Imspex Diagnostic Ltd has achieved a significant milestone: the publication of a new ISO standard for Siloxane testing. Developed ...
Read More →
ONELAB Installation at the Amsterdam University Medical Center
Imspex is pleased to announce the successful installation of the Breathspec® instrument at Amsterdam University Medical Center. This achievement is part of the ONELAB project, ...
Read More →
ISO Certification
Imspex proudly announces its successful renewal of annual registration to ISO 13485:2016 for Medical Devices – Quality Systems – Requirements for Regulatory Purposes. This achievement ...
Read More →
ONELAB Annual Meeting
IMSPEX, as part of the ONELAB European Horizon project, attended the annual meeting held at Ghent University, Belgium, marking the first year completion of the ...
Read More →
ONELAB Installations
Imspex is pleased to announce the successful installation of the Breathspec® instrument at Saitama Medical Centre Hospital (SMCH), Saitama, Japan, an institution affiliated with the ...
Read More →
Bevan Commission NHS 75 Conference
5th – 6th July 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting ...
Read More →
LSX World Congress 2023
3rd – 4th May 2023 Our Group CEO John McKinley will be presenting in the MEDTECH Showcase on the 3rd May at 17:30 as part ...
Read More →
AngloNordic Life Science Conference 2023
Our Group CEO John McKinley and PR, Social Media and Marketing Manager Amber Jacobs will be attending the 19th Annual AngloNordic Life Science Conference 2023 ...
Read More →
MediWales Connects NHS Collaboration Conference 2023
29th June 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with ...
Read More →
BioWales in London
Our Group CEO John McKinley will be presenting in the Company Showcase and participating in the Finance and Funding Panel at BioWales London on Tuesday 14th March ...
Read More →
Arab Health 2023
Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th ...
Read More →
Group B Streptococcus
Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is ...
Read More →
Urine analysis for disease diagnostics or rapid screening
IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic ...
Read More →
TOXI- Triage
In October 2018, Imspex/GAS were in Athens, involved in a full-scale field trial of ground breaking new technologies designed to improve the way the emergency ...
Read More →
TOXI – Triage – DISPERSE exercise
On 22nd May in Mikkeli, Finland, Imspex/GAS took part in the second TOXI- triage field exercise, DISPERSE. DISPERSE scenario simulated a chemical incident in a ...
Read More →
Leicester publication highlights Imspex and GC-IMS
Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis….. ‘GC-IMS shows promise as both a diagnostic tool and ...
Read More →
MediWales Innovation Awards 2022
Our Imspex team look forward to attending this year’s MediWales Innovation Awards at the Mercure Cardiff Holland House on Thursday 8th December. Further information about ...
Read More →
ONELAB
Imspex are proud to be a part of the EU-funded ONELAB project. ONELAB focuses on designing and coordinating mobile laboratory operations for the detection and ...
Read More →
Everyday household items that contain VOCs
VOCs are compounds that easily become gases or vapours and are made up of lots of different elements where one of the elements is carbon.
Read More →
GC-IMS highlights Imspex as Benchmark Technology in VOC Gas
We are very proud to have been highlighted by the ISO committe as the benchmark in VOC Gas technology.
Read More →
Bond Digital Health Partners with Imspex Group
Bond Digital Health and Imspex Diagnostics will be working together on an exciting new technology.
Read More →
What’s your FlavourSpec this Oktoberfest?
For brewers, having access to an instrument such as FlavourSpec could be business transformational.
Read More →
Co-Vid 19 Resilience Innovation success
Imspex Diagnostics was successful in its recent SMARTCymru application for funding to further establish its BreathSpec® technology’s potential as a channel to boost economic recovery ...
Read More →
Low level detection of sulphur compounds in natural gas using the Agilent Micro GC with Ion Mobility Spectrometer
Low level detection of Sulphur compounds in Natural gas using the Agilent Micro GC with Ion Mobility Spectrometer. G.A.S mbH re-engineered its sophisticated Ion Mobility ...
Read More →
BBC exposure for BreathSpec system
BreathSpec system and the BBC – How should we deal with a chemical attack? The BreathSpec system has been gaining much publicity recently. Read about ...
Read More →
Monitoring of Toxic Industrial Chemicals (TICs)
Rapid Monitoring of Dimethyl Sulfate (DMS) in Chemical Plants using GC-IMS Technology Toxic industrial chemicals (TICs) or materials (TIMs) are substances that exhibit harmful effects ...
Read More →
Siloxanes in biogas gas from landfill waste
The generation of electricity from land fill is of increasing interest as a form of renewable energy to be used on site or sold to ...
Read More →
Authenticity of extra virgin olive oil
Want to know about how authentic extra virgin olive oil is? Keep reading… Extra virgin olive oil has always been a popular oil used in ...
Read More →
Imspex Diagnostics Renews ISO 13485 Certification
Imspex Diagnostics Ltd has announced the successful renewal of its ISO 13485:2016 certification, reaffirming its commitment to quality, regulatory compliance, and the delivery of reliable ...
Read More →
Recent Grant Success: Strengthening Our Growth and Capability
Imspex Diagnostics is pleased to confirm that we have secured further support through the Welsh Government SMART Digital and Productivity Accelerator programme, recognising the company’s ...
Read More →
Talking about breath analysis on Radio IntereconomĂa
Santi Dominguez, Imspex’s CEO, spoke with Radio IntereconomĂa’s Gema González on the VisĂon Global programme on 28 July 2021. Listen to their conversation about breath
Moving the momentum forward with Imspex Medical
From the beginning, Imspex Diagnostic’s ambition has been to bring the unique advantages of GC-IMS technology to patients. Our aim has always been to give
Pipeline Corner for Diagnostics at ECCMID 2021
It was a pleasure to be part of the speaker line-up at ECCMID 2021’s Pipeline Corner for Diagnostics on Saturday 10 July, along with speakers
Setting the standard for siloxane measurement in biomethane testing
Imspex Diagnostics recently partnered with the National Physical Laboratory (NPL), @KTNUK and @InnovateUK in their Analysis for Innovators (A4i) programme to investigate the utility of
Breath analysis as a rapid diagnostic for respiratory tract infections
Patients with respiratory tract infections form a large part of general practitioners’ caseloads. In the absence of quick, convenient, accurate, and acceptable ways of identifying
BreathSpec® features at ADTCA 2021
#ADTCA2021 saw more than 75 delegates from 23 countries gather online on 24 June 2021 to discuss how data tech can be used to prevent,